![Florian Ludwig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Florian Ludwig
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Thuja Capital Management BV
![]() Thuja Capital Management BV Investment ManagersFinance Thuja Capital Management BV is a Venture Capital firm, a subsidiary of Thuja Capital Holding BV founded in 2006 by Harrold van Barlingen. Thuja Capital Management BV is headquartered in Utrecht.
4
| Subsidiary | Investment Managers | 4 |
CardiacBooster BV
![]() CardiacBooster BV MiscellaneousMiscellaneous CardiacBooster BV operates as a non classified establishment company. It provides cardiac support to patients. The company was founded by Ludwig Florian & van Dort Daniel and is headquartered in Nijmegen, the Netherlands.
1
| Holding Company | Miscellaneous | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Florian Ludwig tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
NightBalance BV
![]() NightBalance BV Medical DistributorsDistribution Services NightBalance BV develops and markets sensor-devices for the treatment of sleep apnea. It offers sleep position trainer, a small and light aid which can be worn around the chest with an ergonomic band. The firm's a sleep position sensor which gradually and comfortably trains patients using vibrations to not sleep on their back. The company was founded by Eline van Beest and Thijs van Oorschot in 2009 and is headquartered in The Hague, the Netherlands. | Medical Distributors | Director/Board Member Chief Executive Officer | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
Wageningen University | College/University | Doctorate Degree | |
Cristal Delivery BV
![]() Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Astellas Pharma SAS
![]() Astellas Pharma SAS Medical DistributorsDistribution Services Astellas Pharma SAS wholesales pharmaceutical products. The company was founded in 2005 and is headquartered in Levallois-Perret, France. | Medical Distributors | Corporate Officer/Principal | |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Janssen Pharmaceutica NV
![]() Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mellon Medical BV
![]() Mellon Medical BV Medical SpecialtiesHealth Technology Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
Alveron Pharma BV
![]() Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
EsoBiotec SA
![]() EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Pan Cancer T
![]() Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member | |
Nutrileads BV
![]() Nutrileads BV Food: Major DiversifiedConsumer Non-Durables Nutrileads BV develops food ingredi?nts with a specific nutritional value. It identifies promising lead ingredients, develops sustainable and commercially viable production processes and initiates scientific and clinical programs to test the health effects. The company was founded in 2012 by Erik Dam and Ruud Albers and is headquartered in Wageningen, the Netherlands. | Food: Major Diversified | Director/Board Member | |
FABPulous BV
![]() FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Chairman | |
Centre for Drug Design & Discovery
![]() Centre for Drug Design & Discovery Centre for Drug Design & Discovery is a Private Equity/Venture Capital firm, a subsidiary of KU Leuven Research & Development and founded in 2006. Centre for Drug Design & Discovery is headquartered in Leuven. | Private Equity Investor | ||
Cytura Therapeutics BV
![]() Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Chairman | |
Corgo NV
![]() Corgo NV Miscellaneous Commercial ServicesCommercial Services Corgo NV specializes in corporate consulting services. The company determines the required profiles for client’s new directors, engages a network of professional external directors, recommends suitable candidates, and refers search specialists. It was founded by Karel Plasman in 2003 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
The Lewin Group, Inc.
![]() The Lewin Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lewin Group, Inc. operates as a health care and human services consulting firm. Its services include modeling, statistics, and actuarial analysis, policy research and data analysis, program effectiveness, strategic planning, and technical assistance. The company was founded by Lawrence S. Lewin in 1970 and is headquartered in Falls Church, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Boston Consulting Group & Cie SARL
![]() The Boston Consulting Group & Cie SARL Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group & Cie SARL provides management consulting services. Its practice areas include branding, marketing, corporate finance, globalization, and information technology. The company is a subsidiary of The Boston Consulting Group. The firm was founded in 1972 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Hemics BV
![]() Hemics BV Medical SpecialtiesHealth Technology Hemics BV develops and manufactures medical imaging devices. Its systems are based on patented optical inflammation detection technology, a non-invasive, fast and operator independent method that supports rheumatologists in objective assessment of inflammatory status, a key parameter in the treatment of patients with RA. The company was founded by Wouter Rensen, Michiel van Beek and Petra van den Elsen on September 1, 2011 and is headquartered in Eindhoven, the Netherlands. | Medical Specialties | Chairman | |
AlpInvest Partners BV
![]() AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands. | Investment Managers | Director of Investments | |
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Thuja Capital BV
![]() Thuja Capital BV Investment ManagersFinance Thuja Capital BV invests in privately held early-stage biotechnology and medical device companies that are based in the Benelux. The fund can act as lead investor, although it also can co-invest alongside an international syndicate of VC investors. | Investment Managers | Chief Executive Officer | |
Thuja Capital Holding BV
![]() Thuja Capital Holding BV Financial ConglomeratesFinance Thuja Capital Holding BV is a venture capital firm that manages multiple funds focused on building and scaling companies in the fields of pharmaceuticals, medtech, and digital health. The private company is based in Utrecht, Netherlands, and has subsidiaries in the Netherlands. The Dutch company's investments aim to generate a financial return for investors while positively impacting the health and well-being of patients. The company was founded by Harrold van Barlingen, who has been the CEO since incorporation. | Financial Conglomerates | Chief Executive Officer | |
Indigo Diabetes NV
![]() Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member | |
ATRO Medical BV
![]() ATRO Medical BV Medical SpecialtiesHealth Technology ATRO Medical BV develops trammpolin meniscus implants. The company was founded by Tony van Tienen and Jan Hunik on July 17, 2016 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Chairman | |
River Biomedics B V I.O.
![]() River Biomedics B V I.O. Medical SpecialtiesHealth Technology River Biomedics B V I.O. is a Dutch biotech company that focuses on cardiac drug discovery. The company is based in Enschede, Netherlands. The company develops novel therapies for cardiac diseases by directly targeting the heart muscle using human predictive 3D in-vitro models and human induced pluripotent stem cell (hiPSC) technology. The company aims to address high unmet medical needs and provide detailed clinically relevant read-outs through high-throughput in-house screening platforms. River Biomedics values partnerships and strives for novelty by mimicking nature and connecting biology and engineering. The company was founded by Marcelo Ribeiro, Robert Passier, Lisanne Blauw, and the CEO is Nicky Cooper. | Medical Specialties | Founder |
Statistiche
Distribuzione geografica
Paesi Bassi | 22 |
Belgio | 9 |
Francia | 4 |
Germania | 3 |
Stati Uniti | 2 |
Settori
Health Technology | 18 |
Commercial Services | 9 |
Finance | 4 |
Distribution Services | 3 |
Consumer Services | 3 |
Posizioni
Director/Board Member | 20 |
Chairman | 5 |
Founder | 5 |
Private Equity Investor | 4 |
Chief Executive Officer | 4 |
Contatti più connessi
- Borsa valori
- Insiders
- Florian Ludwig
- Connessioni Società